GlassScriptPhysician profile
James Rufus Dockery
NPI 1962591289
$5,551.36
in general payments reported to CMS, 2019-2025
49 companies · $733 in 2025
The $733 reported for 2025 was more than what 81% of Gynecology providers received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $888 · 2020: $458 · 2021: $795 · 2022: $1,112 · 2023: $998 · 2024: $567 · 2025: $733.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,125 · Education: $173.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,125.37 |
| Education | $172.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $843.60 | 2019-2025 | Liletta, Lo Loestrin Fe |
| Radius Health, INC. | $620.01 | 2020-2025 | Tymlos |
| Astellas Pharma US INC | $596.34 | 2019-2025 | Veozah, Myrbetriq |
| Pfizer INC. | $459.73 | 2019-2024 | |
| Sumitomo Pharma America, INC. | $403.28 | 2023-2025 | Gemtesa, Myfembree |
| Amgen INC. | $273.29 | 2019-2023 | Evenity, Prolia |
| Mayne Pharma Commercial LLC | $207.74 | 2021-2025 | |
| Hologic Sales and Service, LLC | $153.97 | 2019-2025 | Aptima |
| Bayer Healthcare Pharmaceuticals INC. | $150.85 | 2019-2025 | |
| Myovant Sciences INC. | $137.06 | 2021-2022 | |
| Exeltis, USA INC. | $126.47 | 2021-2023 | Slynd |
| Medtronic, INC. | $107.50 | 2021-2023 | Interstim |
| Therapeuticsmd, INC. | $107.37 | 2019-2022 | |
| Millicent US INC | $106.57 | 2023-2025 | Intrarosa, Femring |
| Duchesnay USA Incorporated | $92.97 | 2019 |
Show all 48 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Dockery listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.